Approvals (Drugs@FDA)

FULVICIN P/G 330, FULVICIN P/G, FULVICIN P/G 165

CHARTWELL RX · GRISEOFULVIN, ULTRAMICROSIZE

ANDA061996Generic (ANDA)Prescription
Open FDA's page for this record
Application number
ANDA061996
Sponsor name
CHARTWELL RX
Submissions
  1. Submission type
    SUPPL
    Submission number
    7
    Submission status
    AP
    Submission status date
    20010126
    Submission class code
    MANUF (CMC)
    Submission class code description
    Manufacturing (CMC)
  2. Submission type
    ORIG
    Submission number
    1
    Submission status
    AP
    Submission status date
    19820406
  3. Submission type
    SUPPL
    Submission number
    9
    Submission status
    AP
    Submission status date
    20260901
    Review priority
    STANDARD
    Submission class code
    LABELING
    Submission class code description
    Labeling
Products
  1. Product number
    004
    Reference drug
    No
    Brand name
    FULVICIN P/G 330
    Reference standard
    No
    Dosage form
    TABLET
    Route
    ORAL
    Marketing status
    Prescription
    Te code
    AB
    Active ingredients
    1. Name
      GRISEOFULVIN, ULTRAMICROSIZE
      Strength
      330MG
  2. Product number
    002
    Reference drug
    No
    Brand name
    FULVICIN P/G
    Reference standard
    No
    Dosage form
    TABLET
    Route
    ORAL
    Marketing status
    Prescription
    Te code
    AB
    Active ingredients
    1. Name
      GRISEOFULVIN, ULTRAMICROSIZE
      Strength
      250MG
  3. Product number
    003
    Reference drug
    No
    Brand name
    FULVICIN P/G 165
    Reference standard
    No
    Dosage form
    TABLET
    Route
    ORAL
    Marketing status
    Prescription
    Te code
    AB
    Active ingredients
    1. Name
      GRISEOFULVIN, ULTRAMICROSIZE
      Strength
      165MG
  4. Product number
    001
    Reference drug
    No
    Brand name
    FULVICIN P/G
    Reference standard
    No
    Dosage form
    TABLET
    Route
    ORAL
    Marketing status
    Prescription
    Te code
    AB
    Active ingredients
    1. Name
      GRISEOFULVIN, ULTRAMICROSIZE
      Strength
      125MG
Harmonized identifiers (openFDA)
Application number
ANDA061996
Brand name
ULTRAMICROSIZE GRISEOFULVIN
Generic name
ULTRAMICROSIZE GRISEOFULVIN, GRISEOFULVIN
Manufacturer name
Chartwell RX, LLC, Chartwell RX, LLC., Ayurax, LLC., Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc
Product NDC
62135-501, 62135-494, 62135-495, 73308-435, 23155-863, 23155-864
Product type
HUMAN PRESCRIPTION DRUG
Route
ORAL
Substance name
GRISEOFULVIN
RxCUI
245248, 239239, 242831
SPL ID
2e9858c1-8c99-8a0d-e063-6294a90a59a5, 459d8a07-072f-744c-e063-6394a90a9d87, 2d3fc650-5035-982f-e063-6394a90a6fd4, db35c070-b434-48f2-8ce8-e902d498459a
SPL set ID
640c489e-f491-4805-a390-ef4be43e261b, efb8a660-802c-4ca6-bbff-ad7b48b91aef, 43fc5201-d23c-4d83-9247-baefe03774ef, ae369582-2e4c-48a4-ac42-0a77466654fd
Package NDC
62135-501-30, 62135-494-01, 62135-494-30, 62135-495-01, 62135-495-30, 73308-435-30, 23155-863-01, 23155-864-01
Nui
N0000008732, N0000175085, N0000175848
Pharm class pe
Decreased Mitosis [PE], Microtubule Inhibition [PE]
Pharm class epc
Tubulin Inhibiting Agent [EPC]
UNII
32HRV3E3D5
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.